Why do the French get much greater access to anti-TNF than the British? Vive la difference? Pas necessairement.
Deighton
C
C
Hyrich
K
K
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005602:France; D019983:Guideline Adherence; D054625:Healthcare Disparities; D006801:Humans; D018579:Patient Selection; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D006113:United Kingdom
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha